(R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline

  • Name: (R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline
  • CAS: 38325-02-9
  • Purity: 99%
Inquiry

Details

Excellent chemical plant bulk supply (R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 38325-02-9

  • Molecular Formula: C21H25NO4
  • Molecular Weight: 355.434
  • Vapor Pressure: 1.23E-09mmHg at 25°C 
  • Boiling Point: 487°Cat760mmHg 
  • Flash Point: 140.2°C 
  • PSA: 40.16000 
  • Density: 1.166g/cm3 
  • LogP: 3.41100 

(R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline(Cas 38325-02-9) Usage

General Description

"(R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline" is a complex chemical compound with a molecular structure that consists of a dibenzoquinoline core. It contains four methoxy groups and a methyl group, as well as a tetrahydro ring system. The compound is a derivative of the tetrahydroisoquinoline alkaloid family, and it is known for having various biological activities, including anti-inflammatory, anti-cancer, and anti-fungal properties. The intricate structure and diverse properties of this compound make it an interesting target for further research and potential applications in pharmacology and medicine.

InChI:InChI=1/C21H25NO4/c1-22-7-6-12-9-18(25-4)21(26-5)20-14-11-17(24-3)16(23-2)10-13(14)8-15(22)19(12)20/h9-11,15H,6-8H2,1-5H3/t15-/m1/s1

38325-02-9 Relevant articles

In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT2 and α1 receptors

Heng, Hui Li,Chee, Chin Fei,Thy, Chun Keng,Tee, Jia Ti,Chin, Sek Peng,Herr, Deron R.,Buckle, Michael J. C.,Paterson, Ian C.,Doughty, Stephen W.,Abd. Rahman, Noorsaadah,Chung, Lip Yong

, p. 132 - 138 (2018/10/15)

Compounds with activity at serotonin (5-...

Stereoselective synthesis of aporphine alkaloids using a hypervalent iodine(III) reagent-promoted oxidative nonphenolic biaryl coupling reaction. Total synthesis of (S)-(+)-glaucine

Anakabe, Eneritz,Carrillo, Luisa,Badia, Dolores,Vicario, Jose L.,Villegas, Maite

, p. 1093 - 1101 (2007/10/03)

The aporphine alkaloid (+)-glaucine (8a)...

Enantioselective synthesis of (R)-(-)-laudanosine and (R)-(-)-glaucine from L-ascorbic acid

Czarnocki, Zbigniew,Mieczkowski, Jozef B.,Ziolkowski, Marek

, p. 2711 - 2720 (2007/10/03)

L-Ascorbic acid 1 was converted into L-g...

38325-02-9 Process route

(R)-laudanosine
85-63-2,20412-65-1

(R)-laudanosine

(-)-(R)-glaucine
475-81-0,5630-11-5,7661-70-3,38325-02-9,139341-79-0,139341-81-4

(-)-(R)-glaucine

Conditions
Conditions Yield
With chromium(III) oxide; boron trifluoride diethyl etherate; trifluoroacetic acid; trifluoroacetic anhydride; In dichloromethane; for 48h; Ambient temperature;
83%
C<sub>22</sub>H<sub>25</sub>NO<sub>6</sub>

C22 H25 NO6

(-)-(R)-glaucine
475-81-0,5630-11-5,7661-70-3,38325-02-9,139341-79-0,139341-81-4

(-)-(R)-glaucine

Conditions
Conditions Yield
With lithium aluminium tetrahydride; In diethyl ether; at 0 ℃;

38325-02-9 Upstream products

  • 5630-11-5
    5630-11-5

    (+/-)-glaucine

  • 85-63-2
    85-63-2

    (R)-laudanosine

  • 1699-51-0
    1699-51-0

    laudanosine